{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:16:33Z","timestamp":1789488993356,"version":"build-2803163510"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["810331"],"award-info":[{"award-number":["810331"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tjpad.2026.100643","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T12:37:06Z","timestamp":1783168626000},"page":"100643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7185-3615","authenticated-orcid":false,"given":"Vincent","family":"Pr\u00e9vot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-9718","authenticated-orcid":false,"given":"Markus","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Nogueiras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rasika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tjpad.2026.100643_bib0001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-019-0312-x","article-title":"Dural lymphatics regulate clearance of extracellular tau from the CNS","volume":"14","author":"Patel","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.tjpad.2026.100643_bib0002","article-title":"Tanycytes: bloodhounds of the metabolic brain","author":"Rodriguez-Cortes","year":"2025","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.tjpad.2026.100643_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpblue.2026.100003","article-title":"Tanycytic degeneration impairs tau clearance and contributes to Alzheimer\u2019s disease pathology","volume":"1","author":"Sauv\u00e9","year":"2026","journal-title":"Cell Press Blue"},{"key":"10.1016\/j.tjpad.2026.100643_bib0004","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","article-title":"Metabolic and non-cognitive manifestations of Alzheimer's Disease: the hypothalamus as both culprit and target of pathology","volume":"22","author":"Ishii","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.tjpad.2026.100643_bib0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-819973-2.00015-0","article-title":"Hypothalamic alpha-synuclein and its relation to autonomic symptoms and neuroendocrine abnormalities in Parkinson disease","volume":"182","author":"De Pablo-Fernandez","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.tjpad.2026.100643_bib0006","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-819973-2.00017-4","article-title":"Hypothalamic pathology in Huntington disease","volume":"182","author":"van Wamelen","year":"2021","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.tjpad.2026.100643_bib0007","doi-asserted-by":"crossref","DOI":"10.1126\/science.abq4515","article-title":"GnRH replacement rescues cognition in Down syndrome","volume":"377","author":"Manfredi-Lozano","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.tjpad.2026.100643_bib0008","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s44220-025-00390-x","article-title":"An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders","volume":"3","author":"De Giorgi","year":"2025","journal-title":"Nat Ment Health"},{"key":"10.1016\/j.tjpad.2026.100643_bib0009","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","article-title":"Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions","volume":"34","author":"Imbernon","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.tjpad.2026.100643_bib0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cmet.2013.12.015","article-title":"Hypothalamic tanycytes are an ERK-gated conduit for leptin into the brain","volume":"19","author":"Balland","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.tjpad.2026.100643_bib0011","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s42255-021-00432-5","article-title":"Leptin brain entry via a tanycytic LepR-EGFR shuttle controls lipid metabolism and pancreas function","volume":"3","author":"Duquenne","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.tjpad.2026.100643_bib0012","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41586-024-08350-8","article-title":"Brain-wide cell-type-specific transcriptomic signatures of healthy ageing in mice","volume":"638","author":"Jin","year":"2025","journal-title":"Nature"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580726001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:53:42Z","timestamp":1789487622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580726001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2274580726001676"],"URL":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100643","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tau-ing and fro-ing: the tanycytic shuttle in neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tjpad.2026.100643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100643"}}